Received Feb 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | HR4RB | — |
A 46 years old female patient received a dose of Havrix after a temperature excursion.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 46-year-old female patient who received HAV (Havrix) (batch number HR4RB, expiry date 18-DEC-2025) for prophylaxis. On 02-JAN-2025, the patient received Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced incorrect storage of drug (Verbatim: A 46 years old female patient received a dose of Havrix after a temperature excursion.). The outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 04-FEB-2025 The health care professional reported that a patient got vaccinated with Havrix after a temperature excursion, which led to incorrect storage of drug. The health care professional would like to know if the patient needs to be revaccinated.